Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000087

Director acquired 148,710.49 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SPRINGER TIMOTHY A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-15 Grant or award : show line 1 in the form +24,785.08 $403.47 $9,999,999 24,785.08 I
2023-11-15 Grant or award : show line 2 in the form +123,925.41 $403.47 $49,999,998 123,925.41 D

Table II: Derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-13 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −6,410 0 D
2023-11-13 Returned to the company : show line 4 in the form Stock Option (Right to Buy) −10,000 0 D
2023-11-13 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −10,000 0 D
2023-11-13 Returned to the company : show line 6 in the form Stock Option (Right to Buy) −20,000 0 D
2023-11-13 Returned to the company : show line 7 in the form Stock Option (Right to Buy) −40,000 0 D
2023-11-13 Returned to the company : show line 8 in the form Stock Option (Right to Buy) −40,000 0 D
2023-11-13 Returned to the company : show line 9 in the form Stock Option (Right to Buy) −75,000 $0.93 $69,750 0 D
Loading xslF345X05/wk-form4_1700086801.xml…